Can-Fite BioPharma is Biotechnology in Israel that focus on Fite Biofarma Ltd business. Founded in 1994. They cover business area such as fite Biofarma Ltd, orally bioavailable small molecule therapeutic product, autoimmune inflammatory indication, oncology and liver disease, sexual dysfunction, its platform technology, cancer cell, normal cell, pharmacological intervention, all drug, an excellent safety profile.
1994
( 30 years old in 2024 )
Fite Biofarma Ltd
-
10 Bareket Street
Kiryat Matalon, P.O. Box 7537
Petah-Tikva 49170
Israel
Private
fite Biofarma Ltdorally bioavailable small molecule therapeutic productautoimmune inflammatory indicationoncology and liver diseasesexual dysfunctionits platform technologycancer cellnormal cellpharmacological interventionall drugan excellent safety profile
* We use standard office opening hours in near Can-Fite BioPharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Can-Fite BioPharma is Biotechnology business from Israel that founded in 1994 (30 years old in 2024), Can-Fite BioPharma business is focusing on Fite Biofarma Ltd.
Can-Fite BioPharma headquarter office and corporate office address is located in 10 Bareket Street Kiryat Matalon, P.O. Box 7537 Petah-Tikva 49170 Israel.
Can-Fite BioPharma was founded in Israel.
In 2024, Can-Fite BioPharma is currently focus on Fite Biofarma Ltd sector.
Above is snippet of Google Trends for "Fite Biofarma Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Can-Fite BioPharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
